RxDoctor Payments Data

John Burger, DO

Orthopaedic Surgery · Dover, DENPI 1194089912

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.1% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Johnson & Johnson at 30.6% of the total. Reporting peaked in 2019 at $718 and has fallen 85.2% since, to $106 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in DE, where the typical reported total is $6,222.

$1,287in general payments, 2019–2025

Across 38 payments — averaging $33.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$394
  • Smith+Nephew$299
  • Abbott$141
  • Stryker$117
  • Medical Device Business Services, Inc.$74
  • Endo Pharmaceuticals Inc.$55
  • plus $208 from 7 others

What the payments were for

  • Travel & lodging$373%
  • Food & beverage$1,25097%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,287 in reported general payments places this provider in the 30th percentile of 70 orthopaedic surgery providers in Delaware.

See all orthopaedic surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$329,209
Medicare patients
532
Services billed
2,637

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$10,600
Celecoxib346$8,058
Diclofenac Sodium101$4,780
Oxycodone Hcl202$1,325
Ondansetron Hcl184$1,269
Meloxicam130$671
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$457
Tramadol Hcl72$427
Cephalexin17$120
Prednisone35$105

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Dover

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →